Back to All Events

Resting-State Cerebrovascular Reactivity as a Dementia Biomarker: Navigating Multi-Site Reliability and Hardware Biases

All times are displayed in Eastern Canadian Time (ET).

About the talk: This presentation explores the reliability of resting-state cerebrovascular reactivity (rs-CVR) as a promising non-invasive biomarker for tracking vascular cognitive impairment. We will discuss the findings from a longitudinal "human phantom" dataset, which analyzed functional MRI scans of a single healthy subject acquired across several sites across Canada to quantify technical variance. The session will highlight how scanner hardware introduces significant, spatially heterogeneous biases , and demonstrates why implementing study-specific harmonization is critical for ensuring the integrity of large-scale neuroimaging trials.

Learning Objectives:

  1. Understand the role of resting-state cerebrovascular reactivity as a biomarker for early pathogenesis in dementia.

  2. Identify how hardware-induced technical errors and scanner variations confound multi-site MRI data.

  3. Evaluate the effectiveness of linear harmonization in reducing inter-site variance down to the intra-site physiological noise floor.

About the speaker: Rémi is a PhD student at Université Laval specializing in neuroimaging, computational modeling, and cerebrovascular hemodynamics, with a focus on Alzheimer's disease and dementia. Using artificial intelligence, their current work explores how different vascular imaging modalities, including magnetic resonance angiography and functional MRI, can serve as early, non-invasive biomarkers for dementia.

Previous
Previous
April 9

BHCare Webinar - The Role of Modfiable Risk Factors for Dementia in an Era of Anti-Amyloid Therapy

Next
Next
April 24

MRI Biomarkers for Vascular Cognitive Impairment and Dementia